Disclaimer: this article was submitted by a guest author. Daily News Network is not responsible for the content or accuracy of this press release.
TrialAssure, a leading pharmaceutical technology provider advancing clinical trial disclosure, data sharing, and transparency, announced that its flagship product TrialAssure ANONYMIZE® 3.0 is now available. ANONYMIZE allows users across the pharmaceutical industry the ability to perform data, document, and image anonymization and redaction using machine learning (ML), natural language processing (NLP), and artificial intelligence (AI) to share information with confidence, knowing that patient and company confidential information are protected.
In this latest version, ANONYMIZE 3.0 now includes the following:
● Enhanced user experience, with modernized design and intuitive navigation
● Centralized workbench structure for a comprehensive view of all projects and tasks in one location
● Updated rule structure for a streamlined and efficient and practical anonymization decision-making
● Extended support for additional types of documents, such as Microsoft Office documents and email
● Improved risk score visualization to track progress in mitigating re-identification risks
“This launch ushers in a new era in anonymization to the industry, one which combines advances in AI and deep industry knowledge to drive technological progress in the pharmaceutical industry,” Zach Weingarden, Director of Product Solutions at TrialAssure and AI technology expert.
Weingarden added, “With the technical and visual improvements to ANONYMIZE, the most important information is now at the forefront and is easier to understand. As more regulation, like the EU CTR and CTIS, increases the focus on anonymization in pharma, TrialAssure will be equipped to provide the right options for pharmaceutical companies, vendors, and technology partners alike.”
TrialAssure ANONYMIZE 3.0 now gives users the ability to anonymize more documents, including pre-existing PDF functionality and new document types, including emails and Microsoft Office documents (Word, Excel, and PowerPoint).
Submitted by: Don McLean
